{"log_id": 7143209963506435992, "direction": 0, "words_result_num": 77, "words_result": [{"probability": {"variance": 1e-05, "average": 0.997185, "min": 0.987709}, "location": {"width": 200, "top": 43, "height": 23, "left": 125}, "words": "核准日期:2014年02月10日"}, {"probability": {"variance": 0.001823, "average": 0.987844, "min": 0.782951}, "location": {"width": 453, "top": 67, "height": 29, "left": 126}, "words": "修改日期:2015年04月15日:2015年06月15日;2015年08月18日"}, {"probability": {"variance": 0.000151, "average": 0.994834, "min": 0.958148}, "location": {"width": 335, "top": 110, "height": 41, "left": 482}, "words": "达肝素钠注射液说明书"}, {"probability": {"variance": 0.05536, "average": 0.798765, "min": 0.45803}, "location": {"width": 143, "top": 79, "height": 53, "left": 784}, "words": "影医药有公"}, {"probability": {"variance": 0, "average": 0.90931, "min": 0.90931}, "location": {"width": 34, "top": 124, "height": 18, "left": 1127}, "words": "类"}, {"probability": {"variance": 0.042584, "average": 0.608491, "min": 0.402131}, "location": {"width": 27, "top": 134, "height": 25, "left": 909}, "words": "式"}, {"probability": {"variance": 0.000934, "average": 0.987021, "min": 0.8933}, "location": {"width": 321, "top": 151, "height": 31, "left": 481}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 0.007492, "average": 0.972248, "min": 0.457363}, "location": {"width": 1014, "top": 184, "height": 45, "left": 158}, "words": "警示语:椎管内或硬膜外血肿。当实施椎管内麻醉(脊麻和硬膜外麻醉)或椎管穿刺时应注意,使用低分子肝或肝素类物质预防血栓并"}, {"probability": {"variance": 0.012623, "average": 0.962509, "min": 0.407932}, "location": {"width": 1052, "top": 204, "height": 45, "left": 121}, "words": "发症的病人,有可能引起椎管内或硬膜外血肿,导致长期甚至永久性瘫痪。放置硬膜导管或反复硬膜外穿刺使用影响止血功能的药"}, {"probability": {"variance": 0.001721, "average": 0.982985, "min": 0.846394}, "location": {"width": 210, "top": 229, "height": 21, "left": 122}, "words": "物,如非甾体类抗炎药(NS"}, {"probability": {"variance": 0.008354, "average": 0.972979, "min": 0.520654}, "location": {"width": 768, "top": 229, "height": 43, "left": 404}, "words": "血小板凝制剂或其他抗凝药物等,血肿发生率可能会更高。此种情况,应监测病人神经损害的症状和体"}, {"probability": {"variance": 0.000728, "average": 0.988991, "min": 0.857865}, "location": {"width": 861, "top": 248, "height": 40, "left": 123}, "words": "征,如发现有可能损伤到神经,应紧急处理。医生在对此类病人实施椎管内干预(麻醉或刺)时,应进行利弊权衡"}, {"probability": {"variance": 3e-06, "average": 0.998449, "min": 0.996389}, "location": {"width": 81, "top": 287, "height": 21, "left": 119}, "words": "【药品名称"}, {"probability": {"variance": 8e-06, "average": 0.998003, "min": 0.990212}, "location": {"width": 203, "top": 308, "height": 23, "left": 157}, "words": "通用名称:达肝素钠注射液"}, {"probability": {"variance": 7.4e-05, "average": 0.995688, "min": 0.973082}, "location": {"width": 136, "top": 329, "height": 21, "left": 155}, "words": "商品名称:法安明"}, {"probability": {"variance": 0.01213, "average": 0.952535, "min": 0.682813}, "location": {"width": 101, "top": 350, "height": 20, "left": 156}, "words": "英文名称:Da"}, {"probability": {"variance": 2.1e-05, "average": 0.996976, "min": 0.989125}, "location": {"width": 67, "top": 370, "height": 21, "left": 154}, "words": "汉语拼音"}, {"probability": {"variance": 0.000166, "average": 0.986685, "min": 0.96714}, "location": {"width": 50, "top": 412, "height": 20, "left": 119}, "words": "【成份】"}, {"probability": {"variance": 7.3e-05, "average": 0.996958, "min": 0.960524}, "location": {"width": 336, "top": 430, "height": 29, "left": 158}, "words": "化学名称:达肝素钠,本品属于低分子肝素钠"}, {"probability": {"variance": 0, "average": 0.999327, "min": 0.999146}, "location": {"width": 37, "top": 452, "height": 18, "left": 153}, "words": "组成"}, {"probability": {"variance": 1.9e-05, "average": 0.99717, "min": 0.985718}, "location": {"width": 172, "top": 470, "height": 26, "left": 159}, "words": "支单剂量预灌装注射器"}, {"probability": {"variance": 0.013858, "average": 0.945939, "min": 0.559124}, "location": {"width": 215, "top": 494, "height": 23, "left": 153}, "words": "达肝素钠2500IU(抗x"}, {"probability": {"variance": 0.08575, "average": 0.751492, "min": 0.340344}, "location": {"width": 45, "top": 498, "height": 19, "left": 442}, "words": " IU (t"}, {"probability": {"variance": 0.00112, "average": 0.95719, "min": 0.894067}, "location": {"width": 107, "top": 500, "height": 20, "left": 547}, "words": "700IU(抗Xa"}, {"probability": {"variance": 1e-06, "average": 0.998922, "min": 0.997609}, "location": {"width": 48, "top": 516, "height": 18, "left": 153}, "words": "氯化钠"}, {"probability": {"variance": 1e-06, "average": 0.998692, "min": 0.997673}, "location": {"width": 36, "top": 517, "height": 18, "left": 260}, "words": "适量"}, {"probability": {"variance": 0.002171, "average": 0.977444, "min": 0.83482}, "location": {"width": 184, "top": 536, "height": 20, "left": 151}, "words": "注射用水加至0.2ml"}, {"probability": {"variance": 0.009409, "average": 0.953478, "min": 0.717686}, "location": {"width": 73, "top": 539, "height": 19, "left": 404}, "words": "加至0.2ml"}, {"probability": {"variance": 0.004091, "average": 0.964123, "min": 0.815141}, "location": {"width": 72, "top": 540, "height": 20, "left": 546}, "words": "加至0.3ml"}, {"probability": {"variance": 0.000166, "average": 0.994705, "min": 0.930993}, "location": {"width": 529, "top": 555, "height": 32, "left": 151}, "words": "效价以低分子量肝素第一国际标准中所描述的国际抗Xa单位(IU)表示"}, {"probability": {"variance": 0.000105, "average": 0.995313, "min": 0.961528}, "location": {"width": 182, "top": 597, "height": 21, "left": 150}, "words": "分子量:平均分子量为50"}, {"probability": {"variance": 2.3e-05, "average": 0.997318, "min": 0.984779}, "location": {"width": 133, "top": 618, "height": 21, "left": 151}, "words": "辅料名称:氯化钠"}, {"probability": {"variance": 5.7e-05, "average": 0.991738, "min": 0.97998}, "location": {"width": 50, "top": 657, "height": 20, "left": 113}, "words": "【性状】"}, {"probability": {"variance": 8e-06, "average": 0.997894, "min": 0.989482}, "location": {"width": 237, "top": 678, "height": 26, "left": 151}, "words": "本品为无色或淡黄色的澄明液体"}, {"probability": {"variance": 0.000227, "average": 0.98282, "min": 0.961496}, "location": {"width": 60, "top": 720, "height": 20, "left": 118}, "words": "【适应症】"}, {"probability": {"variance": 6e-06, "average": 0.998666, "min": 0.991846}, "location": {"width": 155, "top": 741, "height": 21, "left": 147}, "words": "治疗急性深静脉血栓"}, {"probability": {"variance": 7.4e-05, "average": 0.997889, "min": 0.944209}, "location": {"width": 692, "top": 760, "height": 35, "left": 148}, "words": "预防急性肾功能衰竭或慢性肾功能不全者进行血液透析和血液过滤期间体外循环系统中的凝血"}, {"probability": {"variance": 3e-05, "average": 0.997823, "min": 0.971461}, "location": {"width": 519, "top": 780, "height": 34, "left": 149}, "words": "治疗不稳定型冠状动脉疾病,如:不稳定型心绞痛和非Q波型心肌梗死"}, {"probability": {"variance": 7e-06, "average": 0.998295, "min": 0.992116}, "location": {"width": 207, "top": 803, "height": 24, "left": 145}, "words": "预防与手术有关的血栓形成"}, {"probability": {"variance": 1e-06, "average": 0.998445, "min": 0.997086}, "location": {"width": 45, "top": 844, "height": 20, "left": 111}, "words": "【规格"}, {"probability": {"variance": 0, "average": 0.759844, "min": 0.759844}, "location": {"width": 220, "top": 864, "height": 66, "left": 165}, "words": "删"}, {"probability": {"variance": 4.3e-05, "average": 0.99133, "min": 0.979804}, "location": {"width": 89, "top": 947, "height": 21, "left": 107}, "words": "【用法用量】"}, {"probability": {"variance": 0.006438, "average": 0.978014, "min": 0.628945}, "location": {"width": 326, "top": 967, "height": 28, "left": 141}, "words": "如果需要可通过测定抗Xa以监测本品的活性"}, {"probability": {"variance": 7e-06, "average": 0.997026, "min": 0.992968}, "location": {"width": 150, "top": 1006, "height": 21, "left": 144}, "words": "治疗急性深静脉血栓"}, {"probability": {"variance": 0.000205, "average": 0.99299, "min": 0.953604}, "location": {"width": 357, "top": 1029, "height": 27, "left": 140}, "words": "达肝素钠可以皮下注射每日一次,也可每日二次"}, {"probability": {"variance": 0.004283, "average": 0.974188, "min": 0.583782}, "location": {"width": 757, "top": 1047, "height": 39, "left": 143}, "words": "每日一次用法:200Ukg体重,皮下注射每日一次。无需监测抗凝血活性。每日总量不可超过18IU"}, {"probability": {"variance": 0.006594, "average": 0.974717, "min": 0.517347}, "location": {"width": 1014, "top": 1068, "height": 44, "left": 144}, "words": "每日二次用法:对于出血风险较高的患者,可采用100IU/kg体重,皮下注射每日二次。通常治疗中无需监测抗凝血活性,但可进行功能性抗"}, {"probability": {"variance": 0.011098, "average": 0.96951, "min": 0.518252}, "location": {"width": 626, "top": 1089, "height": 34, "left": 108}, "words": "Xa检测。皮下注射后3~4小时取血样,可测得最大血药浓度。推荐的血药浓度范围为"}, {"probability": {"variance": 0.001727, "average": 0.98492, "min": 0.76586}, "location": {"width": 564, "top": 1112, "height": 32, "left": 142}, "words": "持续静脉输注用法:推荐的初始剂量为100IU/kg体重,12小时后可重复给药"}, {"probability": {"variance": 0.002753, "average": 0.958336, "min": 0.828561}, "location": {"width": 142, "top": 1102, "height": 21, "left": 725}, "words": "0.5~1.0IU抗Xa/ml"}, {"probability": {"variance": 0.014133, "average": 0.956072, "min": 0.420735}, "location": {"width": 1015, "top": 1131, "height": 42, "left": 143}, "words": "同时可立即开始口服维生素K的拮抗剂抗凝治疗。达肝素钠治疗应持续到凝血酶原复合物(因子ⅡIII、IX和X)降至治疗水平。联合治"}, {"probability": {"variance": 9e-06, "average": 0.998538, "min": 0.990466}, "location": {"width": 148, "top": 1154, "height": 20, "left": 106}, "words": "疗通常至少需要5天"}, {"probability": {"variance": 0.008888, "average": 0.942502, "min": 0.624115}, "location": {"width": 345, "top": 1180, "height": 44, "left": 53}, "words": "三预防血液透析和血液过滤期问凝血"}, {"probability": {"variance": 3.8e-05, "average": 0.994984, "min": 0.975935}, "location": {"width": 280, "top": 1217, "height": 22, "left": 144}, "words": "慢性肾功能衰竭,患者无已知出血风险"}, {"probability": {"variance": 0.000272, "average": 0.991508, "min": 0.926465}, "location": {"width": 502, "top": 1236, "height": 29, "left": 140}, "words": "血液透析和血液过滤不超过4小时:剂量如下或静脉快速注射5000IU"}, {"probability": {"variance": 0.013373, "average": 0.962085, "min": 0.416048}, "location": {"width": 753, "top": 1255, "height": 35, "left": 140}, "words": "血液透析和血液过滤超过4小时:静脉快速注射30~40U/kg体重,继以每小时10~15IU/kg体重静脉输注"}, {"probability": {"variance": 0.001612, "average": 0.991384, "min": 0.69196}, "location": {"width": 1011, "top": 1275, "height": 43, "left": 142}, "words": "正常情况下,患者进行长期血液透析应用本品时,需要调整剂量的次数很少,因而检测抗Xa浓度的次数也很少。给予的剂量通常使血浆抗"}, {"probability": {"variance": 0.004705, "average": 0.975332, "min": 0.664579}, "location": {"width": 248, "top": 1297, "height": 23, "left": 107}, "words": "Xa浓度保持在0.5~1.0IU/ml范围内"}, {"probability": {"variance": 0.002824, "average": 0.980691, "min": 0.770457}, "location": {"width": 286, "top": 1318, "height": 26, "left": 139}, "words": "急性肾功能衰竭,患者有高度出血风险"}, {"probability": {"variance": 0.008209, "average": 0.960679, "min": 0.618656}, "location": {"width": 489, "top": 1338, "height": 30, "left": 138}, "words": "静脉快速注射5~10IU/kg体重,继以每小时4-5IU/kg体重静脉输注"}, {"probability": {"variance": 0.004031, "average": 0.981598, "min": 0.656638}, "location": {"width": 460, "top": 1360, "height": 28, "left": 137}, "words": "进行急性血液透析的患者治疗间歇较短,应全面监测抗Xa水平"}, {"probability": {"variance": 0.014327, "average": 0.944776, "min": 0.642747}, "location": {"width": 175, "top": 1381, "height": 22, "left": 139}, "words": "血浆抗Xa水平应介于0.2"}, {"probability": {"variance": 0, "average": 0.999939, "min": 0.999886}, "location": {"width": 33, "top": 1386, "height": 18, "left": 390}, "words": "之间"}, {"probability": {"variance": 0.000784, "average": 0.991735, "min": 0.845371}, "location": {"width": 486, "top": 1420, "height": 30, "left": 139}, "words": "不稳定型冠状动脉疾病,如:不稳定型心绞痛和非Q波型心肌梗死"}, {"probability": {"variance": 0.000357, "average": 0.98755, "min": 0.922082}, "location": {"width": 347, "top": 1444, "height": 25, "left": 138}, "words": "皮下注射120IU/kg体重,每日二次。最大剂量为"}, {"probability": {"variance": 0.006873, "average": 0.983175, "min": 0.469568}, "location": {"width": 625, "top": 1446, "height": 38, "left": 527}, "words": "U/12小时。至少治疗6天,如医生认为必要可以延长治疗。此后,推荐使用固定剂量进"}, {"probability": {"variance": 0.001141, "average": 0.990782, "min": 0.729902}, "location": {"width": 1050, "top": 1461, "height": 45, "left": 101}, "words": "行延长期治疗,直至进行血管重建操作(例如经皮介人(PCI)或冠状动脉旁路搭桥(CABG))。除非有特别的禁忌,推荐使用低剂量乙酰"}, {"probability": {"variance": 1.2e-05, "average": 0.997921, "min": 0.983556}, "location": {"width": 557, "top": 1483, "height": 31, "left": 103}, "words": "水杨酸协同治疗。总疗程不超过45天,应根据患者的性别和体重来选择剂量"}, {"probability": {"variance": 0.000285, "average": 0.992645, "min": 0.916447}, "location": {"width": 599, "top": 1503, "height": 32, "left": 134}, "words": "体重80kg以下的女性患者和体重70kg以下的男性患者:每12小时皮下注射5000IU"}, {"probability": {"variance": 1e-06, "average": 0.999314, "min": 0.998023}, "location": {"width": 79, "top": 1527, "height": 17, "left": 135}, "words": "体重超过8"}, {"probability": {"variance": 9.1e-05, "average": 0.99634, "min": 0.954924}, "location": {"width": 305, "top": 1527, "height": 27, "left": 251}, "words": "含80kg)的女性患者和体重超过70kg(含"}, {"probability": {"variance": 0.000176, "average": 0.990745, "min": 0.956068}, "location": {"width": 293, "top": 1533, "height": 26, "left": 607}, "words": "的男性患者:每12小时皮下注射7500IU"}, {"probability": {"variance": 5.2e-05, "average": 0.995221, "min": 0.973926}, "location": {"width": 201, "top": 1564, "height": 24, "left": 138}, "words": "预防与手术有关的血栓形成"}, {"probability": {"variance": 0.006972, "average": 0.959856, "min": 0.73072}, "location": {"width": 153, "top": 1587, "height": 22, "left": 137}, "words": "中度血栓风险的患者"}, {"probability": {"variance": 0.011323, "average": 0.966812, "min": 0.389834}, "location": {"width": 756, "top": 1606, "height": 34, "left": 135}, "words": "术前1~2小时皮下注射2500IU,术后每日早晨皮下注射2500IU直到患者可以活动,一般需57天或更长"}, {"probability": {"variance": 0.004063, "average": 0.979452, "min": 0.564328}, "location": {"width": 761, "top": 1627, "height": 36, "left": 132}, "words": "持续性活动受限的患者皮下注射5000IU,每天一次,一般需12~14天,可更长。通常不需监测抗凝效果"}, {"probability": {"variance": 0.010407, "average": 0.967106, "min": 0.45648}, "location": {"width": 478, "top": 1669, "height": 30, "left": 133}, "words": "高度血栓风险的患者(患有某些舯瘤的特定患者和某些矫形手术"}], "language": 3}